Published in J Pediatr Gastroenterol Nutr on September 01, 1998
Chronic pericarditis and pericardial tamponade associated with ulcerative colitis. Dig Dis Sci (2008) 0.85
Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? World J Gastroenterol (2006) 0.82
Recurrent pericarditis in children: elevated cardiac autoantibodies. Clin Res Cardiol (2006) 0.78
Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis. J Cardiovasc Ultrasound (2012) 0.77
5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review. Can J Hosp Pharm (2016) 0.75
Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet (1997) 6.66
Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet (1997) 5.58
Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology (1999) 2.91
Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat (2006) 2.39
Growth, nutritional status, body composition, and energy expenditure in prepubertal children with Alagille syndrome. J Pediatr (1999) 1.95
Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet (1998) 1.57
Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am (1999) 1.49
Alagille syndrome. J Med Genet (1997) 1.47
Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr (1999) 1.46
Consequences of JAG1 mutations. J Med Genet (2003) 1.44
Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology (1997) 1.41
Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization. Am J Med Genet (1997) 1.41
The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome. Hum Mol Genet (1999) 1.27
Clinical and molecular genetics of Alagille syndrome. Curr Opin Pediatr (1999) 1.26
Molecular analysis of 24 Alagille syndrome families identifies a single submicroscopic deletion and further localizes the Alagille region within 20p12. Am J Hum Genet (1995) 1.16
Single toxin detection is inadequate to diagnose Clostridium difficile diarrhea in pediatric patients. Gastroenterology (1998) 1.14
Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome. Hepatology (1987) 1.11
Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis. J Clin Gastroenterol (1996) 1.11
Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology (1997) 1.06
Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis (1996) 1.04
Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet (1999) 1.03
Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr (2000) 1.03
Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am J Cardiol (1991) 1.02
Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients. Hum Mutat (2001) 0.96
Cytologically balanced t(2;20) in a two-generation family with alagille syndrome: cytogenetic and molecular studies. Am J Hum Genet (1994) 0.96
Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr (1999) 0.93
Chronic intestinal pseudoobstruction associated with fetal alcohol syndrome. Dig Dis Sci (1997) 0.92
Bone mineral density in children and young adults with Crohn's disease. Inflamm Bowel Dis (1999) 0.89
Ruptured retrocecal appendicitis in an adolescent presenting as portal-mesenteric thrombosis and pylephlebitis. J Pediatr Gastroenterol Nutr (1998) 0.87
Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease. Am J Gastroenterol (2001) 0.85
Intravenous sedation in pediatric upper gastrointestinal endoscopy. Gastrointest Endosc (1995) 0.83
Colitis associated with alpha interferon? J Clin Gastroenterol (1997) 0.83
Site of reovirus replication in liver is determined by the type of hepatocellular insult. J Virol (1990) 0.80
Pediatric Crohn's disease: risk factors for postoperative recurrence. Am J Gastroenterol (2001) 0.80
HIV as a cause of giant cell hepatitis. Hum Pathol (1988) 0.79
A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res (1997) 0.79
A new category of causes of intrahepatic cholestasis. Pediatr Pathol (1992) 0.78
Intestinal perforation in Ehlers-Danlos syndrome after enema treatment for constipation. J Pediatr Gastroenterol Nutr (1998) 0.76
Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children. J Clin Gastroenterol (2000) 0.76
Inflammatory bowel disease in children. Med Clin North Am (1994) 0.75
Transfusion-acquired Plasmodium malariae infection in two premature infants. Pediatrics (1983) 0.75
Bile canalicular morphometry in arteriohepatic dysplasia. Hepatology (1988) 0.75
The Alagille's syndrome and its anaesthetic considerations. Paediatr Anaesth (1998) 0.75
Angiostrongylus costaricensis enterocolitis mimics Crohn's disease. J Pediatr Gastroenterol Nutr (1993) 0.75